Neurocognitive deficits in major depression and a new theory of ADHD: A model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals

Medical Hypotheses

Volumn 68, Issue 1, 2007, Pages 210-221

  Vakalopoulos, C ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; MONOAMINE; MUSCARINIC RECEPTOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AMNESIA; ARTICLE; ATTENTION DEFICIT DISORDER; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; DRUG ANTAGONISM; DRUG INHIBITION; HIPPOCAMPUS THETA RHYTHM; HUMAN; HYPERACTIVITY; HYPOTHESIS; IMPULSIVENESS; LEARNING; LONG TERM MEMORY; MAJOR DEPRESSION; MEMORY CONSOLIDATION; MEMORY DISORDER; MONOAMINERGIC SYSTEM; MOOD; NEOCORTEX; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROMODULATION; PHENOTYPE; PRIORITY JOURNAL; RUMINATION; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SLOW WAVE SLEEP;

EID: 33750630087     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.07.018     Document Type: Article

References (64)

1. Vakalopoulos C. Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia. Med Hyp 66 (2006) 394-431
2. Carr D.B., Cooper D.C., Ulrich S.L., Spruston N., and Surmeier D.J. Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase c-dependent mechanism. J Neurosci 22 (2002) 6846-6855
3. Pazos A., Probst A., and Palacios J.M. Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21 (1987) 97-122
4. Fricker A.D., Rios C., Devi L.A., and Gomes I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Mol Brain Res 138 (2005) 228-235
5. Vakalopoulos C. A scientific paradigm for consciousness: a theory of premotor relations. Med Hyp 65 (2005) 766-784
6. Davis G.W., Schuster C.M., and Goodman C.S. Genetic dissection of structural and functional components of synaptic plasticity. III. CREB is necessary for presynaptic plasticity. Neuron 17 (1996) 669-679
7. Bakker R.A., Casarosa P., Timmerman H., Smit M.J., and Leurs R. Constitutively active Gq/11-coupled receptors enable signaling by coexpressed Gi/o-coupled receptors. J Biol Chem 279 (2004) 5152-5161
8. Evans K.L.J., Cropper J.D., Berg K.A., and Clarke W.P. Mechanisms of regulation of agonist efficacy at the 5-HT1A receptor by phospholipid-derived signaling components. J Pharmacol Exp Ther 297 (2001) 1025-1035
9. Berg K.A., Clarke W.P., Sailstad C., Saltzman A., and Maayani S. Mol Pharmacol 46 (1994) 477-484
10. Neve K.A., Seamans J.K., and Trantham-Davidson H. Dopamine receptor signaling. J Rec Sig Trans 24 (2004) 165-205
11. Hopf F.W., Cascini M.G., Gordon A.S., Diamond I., and Bonci A. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein βγ subunits. J Neurosci 23 (2003) 5079-5087
12. Yuan Q., Harley C.W., and McLean J.H. Mitral cell β1 and 5-HT2A receptor colocalization and cAMP coregulation: a new model of norepinephrine-induced learning in the olfactory bulb. Learn Mem 10 (2003) 5-15
13. McLean J.H., Darby-King A., and Hodge E. 5-HT2 receptor involvement in conditioned olfactory learning in the neonate rat pup. Behav Neurosci 110 (1996) 1426-1434
14. Wang S.-J., Cheng L.-L., and Gean P.-W. Cross-modulation of synaptic plasticity by β-adrenergic and 5-HT1A receptors in the rat basolateral amygdala. J Neurosci 19 (1999) 570-577
15. Tan X., Sanders P., Bolado J., and Whitney M. Integration of G-protein coupled receptor signaling pathways for activation of a transcription factor (EGR-3). Geno Prot Bioinfo 1 (2003) 173-179
16. Mujica-Parodi L.R., Yeragani V., and Malaspina D. Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology 51 (2005) 10-15
17. Toichi M., Kubota Y., Murai T., Kamio Y., Sakihama M., Toriuchi T., et al. The influence of psychotic states on the autonomic function in schizophrenia. Int J Psychophysiol 31 (1999) 147-154
18. Zahn T.P., Carpenter W.T., and McGlashan T.H. Autonomic nervous system activity in acute schizophrenia. Arh Gen Psych 38 (1981) 251-258
19. Zahn T.P., Jacobsen L.K., Gordon C.T., McKenna K., Frazier J.A., and Rapaport J.L. Arch Gen Psych 54 (1997) 904-912
20. Gais S., and Born J. Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation. Proc Nat Ac Sci 101 (2003) 2140-2144
21. Meeter M., Talamini L., Schmitt J.A.J., and Riedel W.J. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology 31 (2006) 712-720
22. Vythilingham M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psych 56 (2004) 101-112
23. Dilsaver S.C. Cholinergic mechanisms in depression. Brain Res Rev 11 (1986) 285-316
24. Harmer C.J., Mackay C.E., Reid C.B., Cowen P.J., and Goodwin G.M. Antidepressant drug treatment modifies the neural processing of nonconscious cues. Biol Psych 59 (2006) 816-820
25. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., and Mintum M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psych 50 (2001) 651-658
26. Watkins P.C., Mathews A., Williamson D.A., and Fuller R.D. Mood-congruent memory in depression: emotional priming or elaboration?. J Abn Psychol 101 (1992) 581-586
27. Denny E.B., and Hunt R.R. Affective valence and memory in depression: dissociation of recall and fragment completion. J Abn Psychol 101 (1992) 575-580
28. Nissen M.J., Knopman D.S., and Schacter D.L. Neurochemical dissociation of memory systems. Neurology 37 (1987) 789-794
29. Thiel C.M., Henson R.N.A., Morris J.S., Friston K.J., and Dolan R.J. Pharmacological modulation of behavioral and neuronal correlates of repetition priming. J Neurosci 21 (2001) 6846-6852
30. Thiel C.M., Henson R.N., and Dolan R.J. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacology 27 (2002) 282-292
31. Bentley P., Vuilleumier P., Thiel C.M., Driver J., and Dolan R.J. J Neurophysiol 90 (2003) 1171-1181
32. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Nat Ac Sci 93 (1996) 3908-3913
33. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., et al. Stress-induced changes in cerebral metabolites, hippocampal volume and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Nat Ac Sci 98 (2001) 12796-12801
34. Magarinos A.M., McEwen B.S., Flugge G., and Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 15 (1996) 3534-3540
35. Muller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J.G., Holsboer F., and Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 14 (2001) 1603-1612
36. Nolen-Hoeksema S., Morrow J., and Fredrickson B.L. Response styles and the duration of episodes of depressed mood. J Abn Psychol 102 (1993) 20-28
37. Caligiuri M.P., and Ellwanger J. Motor and cognitive aspects of motor retardation in depression. J Affect Disord 57 (2000) 83-93
38. Sabbe B., Van Hoof J.J.M., Hulstijn W., and Zitman F.G. Changes in fine motor retardation in depressed patients treated with fluoxetine. J Affect Disord 40 (1996) 149-157
39. Sabbe B., Van Hoof J., Hulstijn W., and Zitman F. Depressive retardation and treatment with fluoxetine: assessment of motor component. J Affect Disord 43 (1997) 53-61
40. Hopkins R.O., Waldram K., and Kesner R.P. Sequences assessed by declarative and procedural tests of memory in amnesic patients with hippocampal damage. Neuropsychologia 42 (2004) 1877-1886
41. Austin M.-P., Mitchell P., and Goodwin G.M. Cognitive deficits in depression. Br J Psychiat 178 (2001) 200-206
42. Porter R.J., Gallagher P., Thompson J.M., and Young A.H. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiat 182 (2003) 214-220
43. Weingartner H., Cohen R.M., Murphy D.L., Martello J., and Gerdt C. Cognitive processes in depression. Arch Gen Psychiat 38 (1981) 42-47
44. Calev A., and Erwin P.G. Recall and recognition in depressives: use of matched tasks. Br J Clin Psychol 24 (1985) 127-128
45. Cole K.D., and Zarit S.H. Psychological deficits in depressed medical patients. J Nerv Ment Dis 172 (1984) 150-155
46. Vargha-Khadem F., Gadian G.D., Watkins K.E., Connelly A., Van Paesschen W., and Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science 277 (1997) 376-380
47. Abas M.A., Sahakian B.J., and Levy R. Neuropsychological deficits and CT scan changes in elderly depressives. Psychol Med 20 (1990) 507-520
48. Brown R.G., Scott L.C., Bench C.J., and Dolan R.J. Cognitive function in depression: its relationship to the presence and severity of intellectual decline. Psychol Med 24 (1994) 829-847
49. Solanto M.V. Attention-deficit/hyperactivity disorder: clinical features. In: Solanto M.V., Arnsten A.F.T., and Castellanos F.X. (Eds). Stimulant drugs and ADHD, basic and clinical neuroscience (2001), Oxford University Press 3-30
50. Sagvolden T., Johansen E.B., Aase H., and Russell V.A. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28 (2005) 397-419
51. Losier B.J., McGrath P.J., and Klein R.M. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psych 37 (1996) 971-987
52. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121 (1997) 65-94
53. Kempton S., Vance A., Maruff P., Costin E.L.J., and Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med 29 (1999) 527-538
54. Rhodes S.M., Coghill D.R., and Matthews K. Methylphenydate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology 175 (2004) 319-330
55. Borcherding B., Thompson K., Kruesi M., Bartko J., Rapoport J.L., and Weingartner H. Automatic and effortful processing in attention deficit/hyperactivity disorder. J Abn Child Psychol 16 (1988) 333-345
56. Weingartner H., Rapoport J.L., Buchsbaum M.S., Bunney Jr. W.E., Ebert M.H., Mikkelsen E.J., et al. Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. J Abn Psychol 89 (1980) 29-37
57. Tannock R., Purvis K.L., and Schachar R.J. Narrative abilities in children with attention deficit hyperactivity disorder and normal peers. J Abn Child Psychol 21 (1993) 103-117
58. Pliszka S.R. Comparing the effects of stimulant and non-stimulant agents on catecholamine function: implications for theories of ADHD. In: Solanto M.V., Arnsten A.F.T., and Castellanos F.X. (Eds). Stimulant drugs and ADHD, basic and clinical neuroscience (2001), Oxford University Press 332-352
59. Sagvolden T., and Sergeant J.A. Attention deficit/hyperactivity disorder-from brain dysfunctions to behaviour. Behav Brain Res 94 (1998) 1-10
60. Sagvolden T., Aase H., Zeiner P., and Berger D. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav Brain Res 94 (1998) 61-71
61. Koschack J., Kunert H.J., Derichs G., Weniger G., and Irle G. Impaired and enhanced attentional function in children with attention deficit/hyperactivity disorder. Psychol Med 33 (2003) 481-489
62. Sprague R.L., and Sleator E.K. Methylphenidate and hyperkinetic children: differences in dose effects on learning and social behavior. Science 198 (1977) 1274-1276
63. Tannock R., Schachar R., and Logan G. Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. J Abn Child Psychol 23 (1995) 235-266
64. Fuggetta G.P. Impairment of executive functions in boys with attention deficit-hyperactivity disorder. Child Neuropsychol 12 (2006) 1-21